On June 27th, China Medical and Health Industry Symbiosis Conference (Menet Conference) was grandly opened in Huzhou, Zhejiang. The conference aimed to create a symbiotic, shared and win-win professional empowerment platform with knowledge, multi-dimension and accurate resource connection.

During the conference, Menet held the award ceremony of "Top 100 Pharmaceutical Industries in China in 2022". With its solid R&D and production strength and steady marketing ability, Tianjin Pharmaceutical Holdings Co., Ltd. was successfully selected into the top ten of the "Top 100 Pharmaceutical Industries in China in 2022" and the "Top 100 of Chinese Medicine Enterprises in China in 2022"!

Relying on the database of terminal patterns of three terminals and six markets exclusively developed and operated by Menet in China for many years, the award has been highly concerned and actively participated by professional research institutions, industry experts and scholars, entrepreneurs and industry colleagues from the two dimensions of innovation driving force and professional promotion for pharmaceutical industrial enterprises. Over the years, the list has regarded as an important reference for all circles to evaluate the strength of domestic pharmaceutical enterprises.

Tianjin Pharmaceutical Holdings Co., Ltd. insists on taking "promoting people's health and well-being, protecting and improving people's lives" as its own responsibility, and strives to become a market-driven and technology empowered health industry leader through modern science and technology and continuous efforts, innovation and reform! In the process of inheritance and development, we adhere to the core value concept of " Love, Integrity, Power", closely focus on people's health needs, constantly improve product quality and service level, and strive to make greater contributions to human health.